Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
It is indicated for the treatment of adult patients with intermediate- or high-r···【more】
Release date：2026-01-05Recommended：11
It is indicated for the treatment of idiopathic pulmonary fibrosis (IPF).【more】
Release date：2026-01-05Recommended：16
On July 22, 2021, Merck & Co., Inc. and Eisai Co., Ltd. jointly announced th···【more】
Release date：2026-01-05Recommended：91
Merck & Co., Inc. and Eisai Co., Ltd. jointly announced today that the U.S. ···【more】
Release date：2026-01-05Recommended：84
Ivosidenib is mainly metabolized by the CYP3A4 enzyme. Co-administration with dr···【more】
Release date：2026-01-04Recommended：149
Ivosidenib has interactions with a variety of drugs, which may affect its effica···【more】
Release date：2026-01-04Recommended：117
Ivosidenib is indicated only for patients with acute myeloid leukemia (AML), cho···【more】
Release date：2025-12-31Recommended：176
Some side effects usually do not require medical treatment and may resolve on th···【more】
Release date：2025-12-31Recommended：136
Ivosidenib is also indicated for the treatment of myelodysplastic syndromes (MDS···【more】
Release date：2025-12-31Recommended：146
On December 26, 2017, Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leading comp···【more】
Release date：2025-12-31Recommended：178
The approval of ivosidenib for its indicated uses by the U.S. Food and Drug Admi···【more】
Release date：2025-12-31Recommended：124
The dosage of Ivosidenib may vary among different patients.What is the recommend···【more】
Release date：2025-12-31Recommended：122
